Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

University of Florida, Gainesville, and a lead investigator in this Phase IIb study.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and a leading cause of cirrhosis, liver cancer and the need for liver transplants. According to the Centers for Disease Control and Prevention (CDC), an estimated 4.1 million Americans (1.6 percent) have been infected with hepatitis C; 3.2 million are chronically infected. The number of new infections per year has declined from an average of 240,000 in the 1980s to about 26,000 in 2004. CDC estimates the number of hepatitis C-related deaths could increase to 38,000 annually by the year 2010, surpassing annual HIV/AIDS deaths.

About PEGASYS

PEGASYS, in combination with COPEGUS (ribavirin), are indicated for the treatment of adults with chronic hepatitis C who have compensated liver disease and have not previously been treated with interferon alpha. Efficacy has been demonstrated in patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are clinically stable (e.g., antiretroviral therapy not required or receiving stable antiretroviral therapy). In addition, PEGASYS in combination with COPEGUS is the first and only FDA-approved regimen for the treatment of chronic hepatitis C in patients coinfected with hepatitis C and HIV. PEGASYS is the only pegylated interferon indicated for the treatment of adult patients with chronic hepatitis B (HBeAg positive and HBeAg negative chronic hepatitis B who have compensated liver disease and evidence of viral replication and liver inflammation).

PEGASYS is dosed at 180mcg as a subcutaneous injection taken once a week. COPEGUS is available as a 200mg tablet, and is administered orally two times a day as a split dose. Roche has backed PEGASYS with the most extensive clinical research program ever undertaken in hepatitis C, with major studies initiated to advance treat
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... CARLSBAD, Calif. , May 28, 2015 ... following webcast:What: , Akcea Therapeutics WebcastWhen: , Thursday, June ... , www.isispharm.com How: , Live on the Internet. ... are unable to participate during the live event, a ... limited time at www.isispharm.com . ABOUT ...
(Date:5/28/2015)...   Mast Therapeutics, Inc. (NYSE MKT: ... adhesion and sealant technology (MAST) platform to develop ... and arterial disease, today announced that Jack Lief ... Directors. Mr. Lief made this decision to avoid ... as President and Chief Executive Officer of Arena ...
(Date:5/28/2015)... 28, 2015  Transportation Insight, a leading ... the SDCE100 Award for the second consecutive ... Executive magazine. Transportation Insight was chosen ... quantify and control supply chain costs associated ... market. Deploying Transportation Insight,s Enterprise Logistics solution ...
Breaking Medicine Technology:Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 2Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 4
... a leading provider of education and professional training for the ... operated by PAREXEL International Corporation (NASDAQ: ... that it has entered into an agreement with the ... University of Singapore Academy of GxP Excellence (NUSAGE), to ...
... SHANGHAI, Oct. 9, 2011 /PRNewswire-Asia/ -- Vaccines made ... Nations (UN) agencies to developing countries, after recognition ... State Food and Drug Administration (SFDA) has complied ... on China,s regulatory system is a precondition that ...
Cached Medicine Technology:PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent 2PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent 3PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent 4PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent 5PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent 6VacChina 2011 International Conference Meets in Shanghai This November 2
(Date:5/28/2015)... Park Cities Pet Sitter is offering a ... class starting Saturday, June 6th at 10:30am. The classes ... Blvd in Dallas, with a maximum of six dogs allowed ... weeks, with no class being held over the 4th of ... In this Intermediate-to-Advanced level class, dogs will solidify their practical ...
(Date:5/28/2015)... 2015 New Jersey Plastic Surgeon and ... world-class results. With over 30 years of experience ... in art, Dr. Rafizadeh knows what it takes to ... Plastic Surgery involves the principles of proportion, harmony and ... level of comfort and personalized care from the moment ...
(Date:5/28/2015)... 28, 2015 As the summer approaches, many ... cool. It’s important to make safety a top priority, however, ... swimming tips. , According to the Centers for Disease Control, ... States, not including boating incidents. Additionally, the National Safety Council ... ages 1 to 4. , Amica is sharing the ...
(Date:5/28/2015)... " Trends Investing ” was featured on NewsWatch ... look at small, medium, and large businesses making an impact ... business expert, conducted the business review and shared with viewers ... should invest their money. , The idea, “let your money ... it and knowing how to succeed are two different things. ...
(Date:5/28/2015)... VA (PRWEB) May 28, 2015 More ... Frozen Yogurt will raise money to help the Muscular ... fighting muscular dystrophy and related life-threatening diseases that limit ... Summer Camp mobile program. , From June 1 to ... that offer customers the opportunity to help send local ...
Breaking Medicine News(10 mins):Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 2Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 3Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3
... Brimble, the 42-year-old mother of three from Brisbane, Queensland ... hours of boarding a cruise liner. She was apparently felled ... hydroxybutyrate, also known as fantasy. ,She had gone ... and two families she was friends with. ...
... in the bacterium that is the most persistent pathogen ... ,Hauptman-Woodward Institute scientists Dr. Andrew Gulick, Eric ... at the University at Buffalo and the New York ... have made this significant discovery which was published in ...
... leader in the field of rodeo injury study and treatment ... rodeo to get a better idea of how frequently cowboys ... today, says Butterwick, anyone, anywhere in the world can access ... mean life-changing, losing a major organ, paralysis, even death. We ...
... who prescribed huge quantity of opiates to patients at his ... years in prison on federal drug charges. ,Thats ... were hoping for, but its still a major victory for ... trial. The prosecutors had asked for a life sentence. Prosecutors ...
... Soldiers losing limbs to enemy bombs are not new but ... who need artificial limbs . ,Minnesota National Guard ... flies with his mangled left hand and the shiny metal ... which the Army gave him. ,The myoelectric Utah ...
... American doctor has pleaded guilty to writing steroid ... part of a business that illegally distributed sex-enhancing drugs to ... second doctor to plead guilty in the federal investigation, which ... hired the doctors.,Santi, 68, of New York, wrote an average ...
Cached Medicine News:Health News:Inquest of Date-rape Drug Victim Attracts Wide Attention in Australia 2Health News:Inquest of Date-rape Drug Victim Attracts Wide Attention in Australia 3Health News:Protein Structure of Pathogens Associated With CF and TB Solved 2Health News:Rounding Up Rodeo Injuries Helps in Prevention 2Health News:Pain Doctor in Virginia Sentenced to Five Years Imprisonment 2Health News:War Stimulates Research Blitz in Prosthetics Industry 2Health News:Doctor Pours Ethics Down The Drain In A Bid To Make A Quick Buck 2
Omni labs carries an extensive line of frames, lenses, soft contacts, RGP lenses, and many other products and services. It supports Zeiss, American optical, Sola, Rodenstock, Zylowear, Eyewear design...
A pre-assembled, hexagonal, revolving tower display with two round 19.75" in diameter adjustable shelves. Enjoy 3.5 square feet of elegant shelf space for your products....
... is a multi-page database similar ... a database of patient information, ... adverse reactions, etc. and can ... and invoices that are necessary ...
A pre-assembled, rectangular shadow box/wall hanging display. It have 3 adjustable shelves with tempered glass, four 50 watt halogen top lights, laminated deck, dust resistant and electrical cord wit...
Medicine Products: